This article announces that Spruce Power Holding Corp has filed a Form 8K for August 12. It briefly mentions the company's stock symbol SPRU and its performance, indicating a +1.44% change. The content primarily serves as a notification of the SEC filing.
Spruce Power reported a solid second quarter in 2026, with operating EBITDA increasing to $26.5 million and net income returning to positive at $3.3 million ($0.14 per share), despite a revenue decline to $30.3 million. The company's profitability improved due to a 21% reduction …
Sprinklr, Inc.'s general counsel, Scott Jacob, sold 71,585 shares of Class A Common Stock on August 10, 2026, at a weighted average price of $6.97 per share. This transaction was carried out under a pre-adopted Rule 10b5-1 trading plan. Following the sale, Jacob's direct …
Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 10 a.m. ET CALL PARTICIPANTS CFO and Co-COO - Kevin Hibbert CEO of Sprott Asset Management - John Ciampaglia Mr. - Whitney George Full Conference Call Transcript Operator: Good morning, ladies and gentlemen, …
Spruce Biosciences (NASDAQ:SPRB) reported a quarterly loss of $6.68 per share, missing the consensus estimate of a $5.79 loss by $0.89. Despite the earnings miss, shares remained flat, and analysts maintain a "Moderate Buy" rating with an average price target of $162.62. The company …
BrightSpring Health Services, Inc. BTSG is well-poised for growth in the coming quarters, backed by strong momentum in Provider Services, expanding specialty and infusion operations, successful integration of acquired home health assets and a scalable home-based care platform. However, the Inflation Reduction Act (IRA)-related …
The 2026 Sprouts Farmers Market espnW Invitational will return for its second year as a doubleheader on December 20 at Bridgestone Arena in Nashville. The event will feature three ESPN Way Too Early Top 25 teams: No. 2 UConn vs. No. 10 LSU, and …
Spruce Biosciences, Inc. (SPRB) reported a significantly widened net loss of $(16.2M) in 2Q 2026, compared to $(2.1M) in 2Q 2025, with diluted loss per share increasing to $(6.68). The company did not report revenue but highlighted regulatory progress with TA-ERT receiving FDA Breakthrough …
Spruce Biosciences (SPRB) reported an increased net loss of $28.5 million for the first half of 2026, up from $16.1 million in 2025, primarily due to higher research and development expenses for its lead asset, tralesinidase alfa (TA-ERT). Despite increased spending, the company significantly …
IQVIA Holdings Inc. IQV stock has rallied over the past three months. The company's shares have jumped 41.5%, outperforming the industry's 17.2% growth and the Zacks S&P 500 Composite's 3.4% uptick. 3-Month Share Price PerformanceZacks Investment Research Image Source: Zacks Investment Research Let us …
* Spruce Biosciences press release [https://seekingalpha.com/pr/20616630-spruce-biosciences-reports-second-quarter-2026-financial-results-and-provides-corporate] (SPRB [https://seekingalpha.com/symbol/SPRB]): Q2 GAAP EPS of -$6.68. * Cash and cash equivalents as of June 30, 2026 were $96.3 million, compared to $48.9 million as of December 31, 2025. * Spruce believes that its cash and cash equivalents …
Spruce Biosciences (NASDAQ:SPRB) has secured a $5.5 million strategic investment from the Cure Sanfilippo Foundation and the National MPS Society. This funding will partially support an expanded access program for its investigational therapy, tralesinidase alfa enzyme replacement therapy (TA-ERT), aimed at patients with Sanfilippo …
NEW YORK, August 12, 2026--(BUSINESS WIRE)--Sprinklr (NYSE: CXM), the definitive, AI-native platform for Unified Customer Experience Management (Unified-CXM), today announced that the company's second quarter financial results will be released before market open on September 2, 2026. The company's earnings press release will be …
Sapient Capital LLC significantly reduced its stake in Sprott Inc. by 95.1% in the second quarter, selling 43,998 shares and retaining a small portion of its holdings. Despite this, institutional investors collectively own 28.3% of Sprott, and analysts generally maintain a "Moderate Buy" rating …
1 Cash-Producing Stock Worth Investigating and 2 That Underwhelm Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. Not all companies are created …
Sprouts Farmers Market (SFM) reported Q2 2026 results with higher sales, slightly lower net income, and plans for 42 new store openings and a $409.79 million share repurchase. The company provided detailed Q3 and full-year 2026 guidance, including projected net sales growth of 5.5% …
CRISPR Therapeutics AG's Chief Financial Officer, Prasad Raju, reported a bona fide gift of 750 Common Shares on August 7, 2026. This transaction is classified as a disposition, and following the gift, Raju directly holds 14,815 Common Shares. The Form 4 filing indicates the …
A holder of Sprout Social, Inc. (SPT) Class A common stock has filed a Form 144 notice to sell 40,000 shares, valued at $404,587.95, on or after August 11, 2026. These shares were acquired as Founders Shares on April 23, 2010. The filing also …
Common Bond Development Group and Harvard Investments are partnering to bring a Sprouts Farmers Market and other retail spaces to the Estrella community in Goodyear. Sprouts will occupy 23,024 square feet of a 35,224-square-foot development, with the remaining area dedicated to smaller retail shops …
Hims & Hers Health, Inc. HIMS reported quarterly adjusted loss per share of 10 cents in second-quarter 2026, against the year-ago period's adjusted earnings per share (EPS) of 17 cents. The metric was wider than the Zacks Consensus Estimate of loss per share of …
Nutiva has launched a new line of globally-inspired sauces and marinades, including Kung Pao, Teriyaki, and Korean BBQ flavors, exclusively at Sprouts Farmers Market. These organic, gluten-free, soy-free, non-GMO products are designed to offer health-conscious consumers convenient, restaurant-quality meals at home using clean ingredients. …
This article provides an analyst report from Morningstar on CRISPR Therapeutics AG (CRSP), noting that its gene-editing therapy Casgevy is gaining traction despite initial commercial hurdles. The report highlights the company's focus on CRISPR/Cas9-based therapeutics. It also includes various market data and related analyst …
Search by ticker symbol or company name and select a result to open its chart.
Sharemaestro
Send a message
Ask a question, report a correction, or send a publisher/support note.
Cookie preferences
Essential cookies keep Sharemaestro secure and working. Choose whether we may use optional persistent analytics and advertising technologies. Limited cookieless server measurement continues for aggregate traffic and security.